skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Mostrar Somente
Refinado por: Base de dados/Biblioteca: ClinicalKey remover assunto: Humans remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Mammalian Target of Rapamycin as a Target in Hematological Malignancies
Mammalian Target of Rapamycin as a Target in Hematological Malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mammalian Target of Rapamycin as a Target in Hematological Malignancies

Abdel-Karim, Isam A., MD, MSc ; Giles, Francis J., MB, MD, FRCPI, FRCPath

Current problems in cancer, 2008-07, Vol.32 (4), p.161-177 [Periódico revisado por pares]

United States: Mosby, Inc

Texto completo disponível

Citações Citado por
2
Double Umbilical Cord Blood Transplantation after Novel Myeloablative Conditioning Using a Regimen of Fludarabine, Busulfan, and Total Lymphoid Irradiation
Double Umbilical Cord Blood Transplantation after Novel Myeloablative Conditioning Using a Regimen of Fludarabine, Busulfan, and Total Lymphoid Irradiation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Double Umbilical Cord Blood Transplantation after Novel Myeloablative Conditioning Using a Regimen of Fludarabine, Busulfan, and Total Lymphoid Irradiation

Abedin, Sameem ; Peres, Edward ; Levine, John E ; Choi, Sung ; Yanik, Gregory ; Couriel, Daniel R

Biology of blood and marrow transplantation, 2014-12, Vol.20 (12), p.2062-2066

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia
Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia

Abla, Oussama ; Ries, Rhonda E. ; Triche, Tim ; Gerbing, Robert B. ; Hirsch, Betsy ; Raimondi, Susana ; Cooper, Todd ; Farrar, Jason E. ; Buteyn, Nathaniel ; Harmon, Lauren M. ; Wen, Hong ; Deshpande, Aniruddha J. ; Kolb, E. Anders ; Gamis, Alan S. ; Aplenc, Richard ; Alonzo, Todd ; Meshinchi, Soheil

Blood advances, 2024-04, Vol.8 (8), p.2005-2017 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Regression of Acquired Immunodeficiency Syndrome-Related Pulmonary Kaposi's Sarcoma After Highly Active Antiretroviral Therapy
Regression of Acquired Immunodeficiency Syndrome-Related Pulmonary Kaposi's Sarcoma After Highly Active Antiretroviral Therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Regression of Acquired Immunodeficiency Syndrome-Related Pulmonary Kaposi's Sarcoma After Highly Active Antiretroviral Therapy

Aboulafia, David M.

Mayo Clinic proceedings, 1998-05, Vol.73 (5), p.439-443 [Periódico revisado por pares]

Rochester, MN: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced Intensity Conditioning: Results of a Phase I Trial
Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced Intensity Conditioning: Results of a Phase I Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced Intensity Conditioning: Results of a Phase I Trial

Abraham, Allistair, M.D ; Cluster, Andrew, M.D ; Jacobsohn, David, M.D., ScM ; Delgado, David, M.D ; Hulbert, Monica L., M.D ; Kukadiya, Divyesh, M.S ; Murray, Lisa, M.A ; Shenoy, Shalini, M.D

Biology of blood and marrow transplantation, 2017-09, Vol.23 (9), p.1587-1592

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse
A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse

Advani, Anjali S ; Shadman, Mazyar ; Ali-Osman, Francis ; Barker, Andrew ; Rybicki, Lisa ; Kalaycio, Matt ; Sekeres, Mikkael A ; de Castro, Carlos M ; Diehl, Louis F ; Moore, Joseph O ; Beaven, Anne ; Copelan, Ed ; Sobecks, Ronald ; Talea, Parisa ; Rizzieri, David A

Clinical lymphoma, myeloma and leukemia, 2010-12, Vol.10 (6), p.473-476 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit–positive Acute Myeloid Leukemia
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit–positive Acute Myeloid Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit–positive Acute Myeloid Leukemia

Advani, Anjali S. ; Tse, William ; Li, Hong ; Jia, Xuefei ; Elson, Paul ; Cooper, Brenda ; Ali-Osman, Francis ; Park, Jino ; Rao, Arati V. ; Rizzieri, David A. ; Wang, Eunice S. ; Cotta, Claudiu V. ; Kalaycio, Matt ; Sobecks, Ronald M. ; Rouphail, Basel ; Maciejewski, Jaroslaw P. ; Fensterl, Jaime ; Carew, Jennifer S. ; Foster, Bethany ; Rush, Mary Lynn ; Tripp, Barbara ; Adams, Donna ; Corrigan, Donna ; Griffiths, Elizabeth A. ; Sekeres, Mikkael A.

Clinical lymphoma, myeloma and leukemia, 2021-02, Vol.21 (2), p.113-118 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Development of Novel Immune Interventions for Prostate Cancer
Development of Novel Immune Interventions for Prostate Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development of Novel Immune Interventions for Prostate Cancer

Agarwal, Neeraj ; Padmanabh, Sumanth ; Vogelzang, Nicholas J

Clinical genitourinary cancer, 2012-06, Vol.10 (2), p.84-92 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Inflammation and cancer: how friendly is the relationship for cancer patients?
Inflammation and cancer: how friendly is the relationship for cancer patients?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inflammation and cancer: how friendly is the relationship for cancer patients?

Aggarwal, Bharat B ; Gehlot, Prashasnika

Current opinion in pharmacology, 2009-08, Vol.9 (4), p.351-369 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
High dose cytarabine, mitoxantrone and l -asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly
High dose cytarabine, mitoxantrone and l -asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly
Material Type:
Artigo 		Adicionar ao Meu Espaço

High dose cytarabine, mitoxantrone and l -asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly

Ahmed, Tamjeed ; Holwerda, Scott ; Klepin, Heidi D ; Isom, Scott ; Ellis, Leslie R ; Lyerly, Susan ; Manuel, Megan ; Dralle, Sarah ; Berenzon, Dmitriy ; Powell, Bayard L ; Pardee, Timothy S

Leukemia research, 2015-09, Vol.39 (9), p.945-949 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (414)

Data de Publicação 

De até
Refinar
  1. Antes de2001  (15)
  2. 2001Até2006  (61)
  3. 2007Até2012  (156)
  4. 2013Até2019  (210)
  5. Após 2019  (59)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.